Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit and Immunotherapy Companion Diagnostic Laboratory Developed Tests

NCT05557474 is registered in ClinicalTrials.gov with Chung Shan Medical University as lead sponsor.

NCT NCT05557474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05557474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit and Immunotherapy Companion Diagnostic Laboratory Developed Tests
Lead sponsor
Chung Shan Medical University
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2021
Completion date
December 31, 2028
Enrollment
236 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, recurrence, surgery